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heart disease (207%), myocardial infarction (204%),
asthma (186%), peripheral vascular disease (184%),
stroke (144%), chronic ischemic heart disease (96%), and
essential hypertension (74%). 
CONCLUSIONS: The percent of patients with comorbid
conditions increases as the observation window increases.
Restricting a search of concomitant diagnoses to a short
timeframe or timeframes of non-continuous enrollment
can result in inaccurate identiﬁcation of chronic comor-
bid conditions of a study population.
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According to the California Healthcare Foundation, 40
percent of Americans will suffer from a chronic disease
by 2010. To reach and positively impact this growing
segment of healthcare consumers, many health plans have
initiated some form of disease management. In attempt-
ing to deliver the most effective and targeted intervention
possible, many plans are turning to the Internet and
online tools for patient-directed self-management. 
OBJECTIVES: The purpose of this research is to 
evaluate the efﬁcacy and patient outcomes associated
with an online disease self-management tool for diabet-
ics. 
METHODS: During 1999–2001, 15,600 unique individ-
uals registered as participants in MyDiabetes.com, 
completing two or more visits. Of these, 160 participants
completed a baseline and follow-up DQOL survey online.
Using the median number of visits (median = 25 visits)
during their participation, this group was then equally
divided into low and high volume visitors to the website.
DQOL scale scores are based on a scale of 100 units
derived from instrument question responses. 
RESULTS: Among the high volume users (more than 25
visits), we found evidence of improvement over baseline
in DQOL scale indicators for satisfaction (Bonferroni
pairwise ttest = 3.7, p < 0.001) and impact (Bonferroni
pairwise ttest = 1.7, p < 0.09). Because this group of par-
ticipants was not randomly assigned to this intervention,
some caution is advised in interpreting these results. It
may be that healthier and more health-conscious patients
with diabetes choose to engage in disease management
programs and report improvement based on subjective
factors. However, among those patients with diabetes
who choose to register and participate in web-enabled
disease self-management programming, this evaluation
provides preliminary evidence of self-reported improve-
ment in patients’ satisfaction and perceived disease
impact associated with an Internet-based program. 
CONCLUSIONS: Web-enable disease self-management
programming for patients with diabetes may therefore be
an effective model for health plans eager to engage their
“at risk” members in patient-directed care. Given the 
magnitude of chronic disease prevalence in the US, more
study of the impact and efﬁcacy associated with these
‘new technology’ interventions is needed.
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OBJECTIVE: Diabetic foot ulcers (DFU) are a common
and costly problem for patients with diabetes. This 
study was undertaken to identify patients with DFU who
required inpatient management in 1995 and their 
readmissions for this problem over a ﬁve-year period, as
well as the resulting costs. 
METHODS: The index DFU admission was identiﬁed 
in the 1995 Massachusetts (MA) inpatient database by
means of primary and secondary ICD-9 diagnosis codes,
excluding cases with any type of lower extremity ampu-
tation or arterial graft. Readmissions for DFU care with
and without lower leg osteomyelitis were tracked over
ﬁve years (1995–1999) by means of a unique patient 
identiﬁer. MA costs, adjusted to national values, were
derived from the all payer state discharge databases. All
accommodations, ancillaries and physician care were
included in the cost estimates, which were adjusted for
medical inﬂation, cost-to-charge ratios, and reported in
2000 US$. 
RESULTS: Males comprised 59% of the index group of
542 patients. The mean age was 65 years (range: 23–99
years) and 1.3% died during the index admission. Of the
survivors, 53% were readmitted at least once (mean 2.1,
range: 1–18) within ﬁve years for DFU management with
or without osteomyelitis for a total of 9,143 inpatient
days, including the index admission. The cumulative 
ﬁve-year cost for the index admission and all readmis-
sions was estimated at $8.5 million. 
CONCLUSIONS: A substantial number of patients with
DFU requiring inpatient management can be expected to
incur additional DFU-related hospital costs within ﬁve
years. This is a conservative cost estimate, as post-acute
care costs, such as rehabilitation and home health care
services, were not included. This information supports the
importance of diligent diabetes management in hopes of
preventing or delaying neuropathic complications, such
as DFU, and programs designed to detect and treat DFUs
at an early stage.
